{
  "url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-2",
  "json_url": "https://openlegislation.uk/eu-decision-2018-945/annex-II/division-2.json",
  "legislation": "eudn/2018/945",
  "legislation_title": "Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-decision-2018-945",
  "path": "annex/II/division/2",
  "kind": "division",
  "number": "2",
  "heading": "ABBREVIATION LIST",
  "text": "1. AFP acute flaccid paralysis\n2. AIDS acquired immune deficiency syndrome\n3. AMR antimicrobial resistance\n4. Anti-HBc hepatitis B core antibody\n5. anti-HCV hepatitis C virus specific antibody\n6. ARI acute respiratory infection\n7. BAL broncho-alveolar lavage\n8. BCG Bacille de Calmette et Guérin\n9. BJ bone and joint infection\n10. BJ-BONE osteomyelitis\n11. BJ-DISC disc space infection\n12. BJ-JNT joint or bursa infection\n13. BoNT botulinum neurotoxin\n14. BSI bloodstream infection\n15. C-CVC catheter-related — central venous catheter\n16. CDAD Clostridium difficile associated diarrhoea\n17. CFU colony-forming unit\n18. CJD Creutzfeldt-Jakob disease\n19. CMV cytomegalovirus\n20. CNRL EU Community Network of Reference Laboratories for human influenza\n21. CNS central nervous system\n22. CNS-IC central nervous system infection — intracranial infection\n23. CNS-MEN central nervous system infection — meningitis or ventriculitis\n24. CNS-SA central nervous system infection — spinal abscess without meningitis\n25. C-PVC catheter-related — peripheral venous catheter\n26. CRI catheter-related infection\n27. CRS Congenital rubella syndrome\n28. CRT capillary refilling time\n29. CSF Cerebrospinal fluid\n30. CT scan computed tomography scan\n31. CVS cardiovascular system infection\n32. CVS-CARD cardiovascular system infection — myocarditis or pericarditis\n33. CVS-ENDO cardiovascular system infection — endocarditis\n34. CVS-MED cardiovascular system infection — mediastinitis\n35. CVS-VASC cardiovascular system infection — arterial or venous infection\n36. DFA direct fluorescent antibody\n37. DFA-TP direct fluorescent antibody test for Treponema pallidum\n38. DNA deoxyribonucleic acid\n39. DPA distal protected aspirate\n40. EARS-Net European Antimicrobial Resistance Surveillance Network\n41. ECDC European Centre for Disease Prevention and Control\n42. ECOFFs epidemiological cut-off values\n43. EEG electroencephalography\n44. EENT eye, ear, nose, throat, or mouth infection\n45. EENT-CONJ eye, ear, nose, throat, or mouth infection — conjunctivitis\n46. EENT-EAR eye, ear, nose, throat, or mouth infection — ear mastoid\n47. EENT-EYE eye, ear, nose, throat, or mouth infection — eye, other than conjunctivitis\n48. EENT-ORAL eye, ear, nose, throat, or mouth infection — oral cavity (mouth, tongue, or gums)\n49. EENT-SINU eye, ear, nose, throat, or mouth infection — sinusitis\n50. EENT-UR eye, ear, nose, throat, or mouth infection — upper respiratory tract, pharyngitis, laryngitis, epiglottitis\n51. EFNS European Federation of Neurological Societies\n52. EIA enzyme immunoassay\n53. ELISA enzyme-linked immunosorbent assay\n54. EM electron microscopy\n55. EUCAST European Committee on Antimicrobial Susceptibility Testing\n56. FAMA fluorescent antibody to membrane antigen\n57. FTA-abs fluorescent treponemal antibody absorption\n58. FUO fever of unknown origin\n59. GI gastrointestinal system infection\n60. GI-CDI gastrointestinal system infection — Clostridium difficile infection\n61. GI-GE gastrointestinal system infection — gastroenteritis (excl. CDI)\n62. GI-GIT gastrointestinal system infection — gastrointestinal tract (esophagus, stomach, small and large bowel, and rectum) excluding gastroenteritis and appendicitis\n63. GI-HEP gastrointestinal system infection — hepatitis\n64. GI-IAB gastrointestinal system infection — intraabdominal, not specified elsewhere including gallbladder, bile ducts, liver (excluding viral hepatitis), spleen, pancreas, peritoneum, subphrenic or subdiaphragmatic space, or other intraabdominal tissue or area not specified elsewhere\n65. HAI healthcare-associated infections\n66. HbeAg hepatitis B e antigen\n67. HbsAg hepatitis B surface antigen\n68. HBV-DNA hepatitis B nucleic acid\n69. HCV-core hepatitis C virus core antigen\n70. HCV-RNA hepatitis C virus nucleic acid\n71. HIV human immunodeficiency virus\n72. HUS haemolytic-uraemic syndrome\n73. IAP intubation-associated pneumonia\n74. IFA indirect fluorescent antibody\n75. IgG immunoglobulin G\n76. IgM immunoglobulin M\n77. ILI influenza-like illness\n78. LGV lymphogranuloma (venereum)\n79. LPS lipopolysaccharides\n80. LRI lower respiratory tract infection, other than pneumonia\n81. LRI-BRON lower respiratory tract infection — bronchitis, tracheobronchitis, bronchiolitis, tracheitis, without evidence of pneumonia\n82. TBE Tick-borne encephalitis",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/2",
    "retrieved_at": "2026-11-01T15:13:03.598650+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}